Repair of Thoracoabdominal Aortic Aneurysms

Recruiting now · Not applicable

Conditions studied: Thoracoabdominal Aneurysm

In brief

The primary objective of the clinical investigation is to assess the use of the Medtronic Valiant Thoracoabdominal Stent Graft System to repair thoracoabdominal aortic aneurysms in patients having appropriate anatomy. The primary intent of the study is to assess safety and preliminary effectiveness of the device. Additionally, the study will assess technical success and treatment success at each follow-up interval.

Key facts

Study ID

NCT03111459

Run by

The Christ Hospital

People needed

15

Starts

2017-08-01

Expected to finish

2029-05-01

Last updated by the study team

2024-02-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• A patient may be entered into the study if the patient has at least one of the following:
• an aneurysm with a maximum diameter of > 5.5 cm or 2 times the normal diameter just proximal to the aneurysm using orthogonal (i.e., perpendicular to the centerline) measurements
• aneurysm with a history of growth > 0.5 cm in 6 months
• saccular aneurysm deemed at significant risk for rupture
• symptomatic aneurysm greater than 4.5 cm
• Axillary or brachial and iliac or femoral access vessel morphology that is compatible with vascular access techniques, devices or accessories, with or without use of a surgical conduit.
• Proximal landing zone for the thoracic bifurcation stent graft that has:
• ≥ 2.5 cm of nonaneurysmal aortic segment including previously placed graft material (neck) distal to the left subclavian artery (LSA) diameter in the range of 26-42 mm.
• adequate distance from the celiac artery, in order to accommodate cannulation from the antegrade access point when considering the total deployed length of the thoracic bifurcation and visceral manifold.
• Minimum branch vessel diameter ≥ 5 mm.
• Iliac artery or aortic distal fixation site, including both native tissue and previously placed graft, greater than or equal to 15 mm in length and diameter in the range of 8 - 25 mm.
• Patient is ≥ 18 years of age.
• Patient has a life expectancy > 1 year.

You may not qualify if…

• Patient is a good candidate for and elects open surgical repair.
• Patient can be treated in accordance with the instructions for use with a legally marketed endovascular prosthesis.
• Patient is eligible for enrollment in a manufacturer-sponsored IDE at the investigational site.
• Patient is unwilling to comply with the follow-up schedule.
• Patient is unable or refuses to give informed consent.
• Urgent or emergent presentation.
• Patient is pregnant or breastfeeding.
• Patient has a contained rupture.
• Patient has a ruptured aneurysm.
• Patient has a dissection in the treated portion of the aorta.
• Obstructive stenting of any or all of the visceral vessels.
• Poor performance status including 2 major system failures (cardiovascular, renal, hepatobiliary, neuromuscular).
• Medical Exclusion Criteria:
• Patient has known sensitivities or allergies to the materials of construction of the devices, including nitinol (Nickel: Titanium), polyester, platinum-iridium, polytetrafluoroethylene (PTFE), platinum, gold, polyethylene, or stainless steel.
• Patient has known hypersensitivity or contraindication to anticoagulation or contrast media that cannot be adequately medically managed.
• Patient has an uncorrectable coagulopathy.
• Patient has a body habitus that would inhibit x-ray visualization of the aorta or exceeds the safe capacity of the equipment.
• Patient has had a major surgical or interventional procedure. unrelated to the treatment of the aneurysm planned < 30 days of the endovascular repair.
• Patient has unstable angina (defined as angina with a progressive increase in symptoms, new onset at rest or nocturnal angina).
• Patient has a systemic or local infection that may increase the risk of endovascular graft infection.
• Baseline creatinine greater than 2.0 mg/dL.
• History of connective tissue disorders (e.g., Marfan Syndrome, Ehler's Danlos Syndrome).
• Anatomical Exclusion Criteria:
• Thrombus or excessive calcification within the neck of the aneurysm.
• Anatomy that would not allow maintenance of at least one patent hypogastric artery.

Where it is running

• The Christ Hospital — Cincinnati, Ohio, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.